Pseudomonas aeruginosa and proteus infections in premature babies and in infants. Therapeutic trial with carbenicillin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002228:Carbenicillin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D008297:Male; D008417:Mastoiditis / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects / Q000302:isolation & purification; D011512:Proteus Infections / Q000188:drug therapy* / Q000517:prevention & control; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D010406:Penicillins; D002228:Carbenicillin